Blog

Biodistribution (BD)

Chief Pharmacist

BD is the in vivo distribution, persistence, and clearance of a gene therapy (GT) product at the site of administration ...

Bioburden

Chief Pharmacist

The level and type (e.g. objectionable or not) of micro-organisms that can be present in raw materials, Active Pharmaceutical Ingredient ...

Biological Activity, Drugs and Matrix

Chief Pharmacist

Biological Activity The specific ability or capacity of the product to achieve a defined biological effect. Potency is the quantitative ...

Blinding in Clinical Trials

Chief Pharmacist

A procedure in which one or more parties to the trial are kept unaware of the treatment assignment(s). Single-blinding usually ...

Bridging Study

Chief Pharmacist

A bridging study is defined as a supplemental study performed in the new region to provide pharmacodynamic or clinical data ...

Business Case

Chief Pharmacist

The reason for making an investment (in whatever form), performing a process or using a tool. It often includes economic ...

Blending in Pharmaceutical Manufacturing

Chief Pharmacist

Blending is defined as the process of combining materials within the same specification to produce a homogeneous intermediate or API. ...

Batch and Batch Number

Chief Pharmacist

Batch A defined quantity of starting material, packaging material or finished pharmaceutical product processed in a single process or series ...

Bracketing

Chief Pharmacist

The design of a stability schedule such that only samples on the extremes of certain design factors, e.g., strength, package ...

GxP Topics

Chief Pharmacist

GxP refers to the guidelines for Good Practice in pharmaceutical industry for ensuring safety and efficacy of products. GxP compliance ...

1235 Next